Rapid Desensitization Procedure for Allergic Reactions to Chemotherapy
DeKalb Medical is proud to announce our new Chemotherapy Rapid Desensitization procedure. Sometimes, cancer patients become allergic to their chemotherapy. The allergic reactions can range from pain, vomiting and weakness to life-threatening conditions including anaphylactic shock. Carboplatin, for example, causes allergic reactions to chemotherapy so often that cancer specialists routinely do skin tests to check for the onset of allergies. Even new treatments like rituximab can cause serious allergies. Approximately 25 percent of patients in the United States develop allergies to platinum-based chemotherapy, and these allergic reactions have prevented some cancer patients from getting the best treatment available for their cancer. Unfortunately, alternative chemo drugs are usually less effective and/or more toxic than the preferred options.
New Treatment Options for Allergic Reactions to Chemotherapy
The good news is that DeKalb Medical now offers a rapid desensitization option for patients who have been forced to halt a cancer treatment due to allergic reactions to chemotherapy. Allergy Specialist George R. Gottlieb, M.D., in partnership with DeKalb Medical’s Cancer Center, has developed a Chemotherapy Rapid Desensitization Treatment program. This rapid desensitization procedure allows cancer patients who have allergic reactions to their chemotherapy medication to receive the best possible treatment by managing the side effects of the much-needed therapy.
Chemotherapy Rapid Desensitization
Desensitization sessions last a total of 6 to 8 hours. Patients arrive at DeKalb Medical’s Cancer Center in the morning, and begin by taking gentle “premedications” to help avoid allergic reactions to chemotherapy. These may include oral antihistamines, ibuprofen and/or aspirin. Throughout the day, Dr. Gottlieb and a team of nurses administer the chemotherapy. At all times, patients are in the care of highly-trained nurses and advanced monitoring equipment that allows for immediate intervention should any reactions begin. Dr. Gottlieb has completed more than 60 rapid desensitization sessions in the first 10 months of this new program, and has been successful in getting 93 percent of patients through the treatment with the chemo drug that is the very best choice for their cancer.
For more information about DeKalb Medical’s Chemotherapy Rapid Desensitization program,call 404.501.EASY or email email@example.com.